;
Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Werfen Group S.A sales and marketing update

    Werfen Group S.A., Barcelona, Spain Business: Diagnostic Werfens Inova Diagnostics Inc. subsidiary launched its Quanta Lite Calprotectin assay worldwide to aid in diagnosing inflammatory bowel disease (IBD). The …

    Published on 6/23/2014
  • Aerocrine, Healthcare 21 Ltd. sales and marketing update

    Aerocrine AB (SSE:AERO), Solna, Sweden Healthcare 21 Ltd., Cork, Ireland Business: Diagnostic Aerocrine granted Healthcare 21 exclusive rights to market Niox Vero and Niox Mino in the U.K. and Ireland. Niox Mino and …

    Published on 1/27/2014
  • Alexza, Ferrer sales and marketing update

    Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Grupo Ferrer Internacional S.A., Barcelona, Spain Business: Neurology Ferrer launched Adasuve Staccato loxapine in Spain. The launch triggered a $1 …

    Published on 1/27/2014
  • Angelini, Helsinn sales and marketing update

    Gruppo Angelini, Rome, Italy Helsinn Healthcare S.A., Pazzallo-Lugano, Switzerland Business: Endocrine/Metabolic Helsinn granted Angelini's CSC Pharmaceuticals Handels GmbH subsidiary exclusive rights to commercialize …

    Published on 1/27/2014
  • Biocon sales and marketing update

    Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Business: Biosimilars, Cancer Biocon said it will launch Canmab - its biosimilar of Herceptin trastuzumab - in India in the first week of February. The Drugs …

    Published on 1/27/2014
  • Biogen Idec sales and marketing update

    Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Business: Autoimmune Biogen Idec launched Fampyra fampridine in Ireland to improve walking ability in patients with multiple sclerosis (MS). Fampyra is not available for …

    Published on 1/27/2014
  • CollabRx, Cynvenio Biosystems sales and marketing update

    CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif. Cynvenio Biosystems Inc., Westlake Village, Calif. Business: Pharmacogenetics CollabRx launched its Therapy Finder for breast cancer patients who order Cynvenio's …

    Published on 1/27/2014
  • CombiMatrix, Galaxy Health Network sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Galaxy Health Network, Arlington, Texas Business: Diagnostic CombiMatrix said U.S. healthcare provider Galaxy Health Network will cover CombiMatrix's molecular diagnostic …

    Published on 1/27/2014
  • Hisamitsu, Shionogi sales and marketing update

    Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan Business: Endocrine/Metabolic Hisamitsu's Noven Pharmaceuticals Inc. subsidiary and Shionogi will exclusively co…

    Published on 1/27/2014
  • Innovative Diagnostic Laboratory LLP sales and marketing update

    Innovative Diagnostic Laboratory LLP, Richmond, Va. Business: Diagnostic Innovative Diagnostic launched the ColonSentry blood test in the U.S. to assess a patient's risk for colorectal cancer. The company launched the …

    Published on 1/27/2014
  • Merz sales and marketing update

    Merz GmbH & Co. KGaA, Frankfurt, Germany Business: Infectious Merz launched an enhanced co-pay program for Naftin naftifine. The allylamine antifungal is available in 1% and 2% formulations in the U.S. to treat …

    Published on 1/27/2014
  • Phosphagenics, Novartis, Themis Medicare Ltd. sales and marketing update

    Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Themis Medicare Ltd. (NSE:THEMISMED; BSE:530199), Mumbai, India Business: Neurology, Drug delivery …

    Published on 1/27/2014
  • Takeda, Osaka University sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Osaka University, Osaka, Japan Business: Infectious Takeda received rights to sell a freeze-dried live attenuated varicella vaccine in Japan from the university'…

    Published on 1/27/2014
  • Vectura, Novartis sales and marketing update

    Vectura Group plc (LSE:VEC), Chippenham, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pulmonary Novartis' Sandoz generic pharmaceuticals division launched AirFluSal Forspiro salmeterol/fluticasone…

    Published on 1/27/2014
  • Akorn, Santen sales and marketing update

    Akorn Inc. (NASDAQ:AKRX), Lake Forest, Ill. Santen Pharmaceutical Co. Ltd. (Tokyo:4536), Osaka, Japan Business: Ophthalmic Akorn acquired from Santen the NDA and all rights to Betimol timolol solution. Betimol is …

    Published on 1/20/2014
  • Alliance Pharma, Bayer sales and marketing update

    Alliance Pharma plc (LSE:APH), Chippenham, U.K. Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Diagnostic, Endocrine/Metabolic Alliance Pharma's Alliance Pharmaceuticals Ltd. subsidiary acquired from Bayer rights …

    Published on 1/20/2014
  • Antares sales and marketing update

    Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Business: Autoimmune Antares launched Otrexup in the U.S. to deliver subcutaneous methotrexate to treat adults with rheumatoid arthritis or psoriasis and children with …

    Published on 1/20/2014
  • Apeiron Biologics, Gen Pharmaceuticals Inc., Medison sales and marketing update

    Apeiron Biologics AG, Vienna, Austria Gen Pharmaceuticals Inc., Ankara, Turkey Medison Pharma Ltd., Petah Tikva, Israel Business: Cancer Apeiron granted Gen exclusive rights to market APN311 in Turkey and Medison …

    Published on 1/20/2014
  • Ariad, Biologics sales and marketing update

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Biologics Inc., Cary, N.C. Business: Cancer Ariad said it relaunched leukemia drug Iclusig ponatinib in the U.S. The biotech began shipping the drug to …

    Published on 1/20/2014
  • Astellas sales and marketing update

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Gastrointestinal Astellas launched Irribow ramosetron orally disintegrating tablets in Japan to treat diarrhea-predominant irritable bowel syndrome (IBS-D) in …

    Published on 1/20/2014
  • CombiMatrix, ProPath sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. ProPath, Dallas, Texas Business: Diagnostic CombiMatrix said ProPath, a physician-owned provider of pathology services, will provide its patients with CombiMatrix's …

    Published on 1/20/2014
  • Curetis, Laboratorios LETI sales and marketing update

    Curetis AG, Holzgerlingen, Germany Laboratorios LETI, Tres Cantos, Spain Business: Diagnostic Curetis granted LETI exclusive rights to commercialize all existing and future Unyvero instruments and consumables in Spain …

    Published on 1/20/2014
  • Elixir Medical sales and marketing update

    Elixir Medical Corp., Sunnyvale, Calif. Business: Cardiovascular Elixir launched its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System in Europe to treat coronary artery disease (CAD). The scaffold is …

    Published on 1/20/2014
  • Epigenomics, Kindstar Global Co. Ltd. sales and marketing update

    Epigenomics AG (Xetra:ECX), Berlin, Germany Kindstar Global Co. Ltd., Beijing, China Business: Diagnostic Epigenomics granted Kindstar exclusive rights to develop and commercialize the Epi proLung BL Reflex assay for …

    Published on 1/20/2014
  • GW Pharma, Ipsen sales and marketing update

    GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K. Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Musculoskeletal, Neurology GW granted Ipsen exclusive rights to promote and …

    Published on 1/20/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993